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Abstract
Background: Recent studies have suggested that eosinophils may have a direct effect on airway smooth muscle
cells (ASMC), causing their proliferation in patients with asthma, but the precise mechanism of the interaction
between these cells remains unknown. We propose that changes in Wnt signaling activity and extracellular matrix
(ECM) production may help explain these findings. Therefore, the aim of this study was to investigate the effect of
eosinophils from asthmatic and non-asthmatic subjects on Wnt-5a, transforming growth factor β1 (TGF-β1), and
ECM protein (fibronectin and collagen) gene expression and ASMC proliferation.
Methods: A total of 18 subjects were involved in the study: 8 steroid-free asthma patients and 10 healthy subjects.
Peripheral blood eosinophils were isolated using centrifugation and magnetic separation. An individual co-culture
of eosinophils with human ASMC was prepared for each study subject. Adhesion of eosinophils to ASMC (evaluated
by assaying eosinophil peroxidase activity) was determined following various incubation periods (30, 45, 60, 120,
and 240 min). The expression of Wnt-5a, TGF-β1, and ECM protein genes in ASMC was measured using quantitative
real-time polymerase chain reaction (PCR) after 24 h of co-culture. Proliferation of ASMC was measured using the
Alamar blue method after 48 h and 72 h of co-culture with eosinophils.
Results: Eosinophils from asthmatic subjects demonstrated increased adhesion to ASMC compared with
eosinophils from healthy subjects (p < 0.05) in vitro. The expression of Wnt-5a, TGF-β1, collagen, and fibronectin
genes in ASMC was significantly higher after 24 h of co-culture with eosinophils from asthmatic subjects, while
co-culture of ASMC with eosinophils from healthy subjects increased only TGF-β1 and fibronectin gene expression.
ASMC proliferation was augmented after co-culture with eosinophils from asthma patients compared with
co-culture with eosinophils from healthy subjects (p < 0.05).
Conclusions: Eosinophils enhance Wnt-5a, TGF-β1, fibronectin, and collagen gene expression in ASMC and
promote proliferation of these cells in asthma.
Trial registration: ClinicalTrials.gov Identifier: NCT02648074.
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Background
Asthma is a chronic inflammatory disorder of the airways
in which many cells and cellular elements play critical
roles. It is characterized by chronic inflammation, which is
associated with airway hyperresponsiveness that leads to
recurrent episodes of coughing, wheezing, breathlessness,
and chest tightness [1]. Eosinophils are circulating granulo-
cytes produced in the bone marrow that can be recruited
to sites of immunological or inflammatory responses [2].
In response to interleukin 5 (IL-5), eosinophils attach to
airway endothelium and, in the presence of cytokines
CCL11 and CCL5, migrate to the submucosa and lamina
propria, where they can make contact with airway
smooth muscle cells (ASMC) in vivo [3]. Recruitment
of eosinophils leads to airway remodeling owing to
secreted eosinophil cytokines and chemokines. Airway
remodeling encompasses cellular and structural changes
in the airway [4]. These changes include subepithelial
fibrosis, smooth muscle hypertrophy/hyperplasia [5, 6],
epithelial cell mucus metaplasia, greater extracellular
matrix (ECM) production [7], and angiogenesis [8, 9].
Increased airway smooth muscle mass is a pathological
feature in individuals with asthma [10].
Halwani et al. showed that integrins of eosinophils
bind to ASMC adhesion molecules and that this inter-
action is required for the release of mediators leading to
ASMC proliferation in asthma [11]. Other studies sug-
gest that eosinophils induce ECM protein expression in
ASMC [12], which enhances ASMC proliferation [13].
However, precisely how eosinophils cause ASMC prolifer-
ation in asthma is unknown. One possible mechanism is
altered noncanonical Wnt signaling in ASMC after direct
contact with eosinophils.
Wnt signaling plays a critical role in the development
of multicellular organisms and the maintenance of adult
tissue homeostasis [14, 15]. Wnt-5a is a member of a
family of 19 cysteine-rich secreted glycoproteins; it acti-
vates noncanonical Wnt signaling [16] through c-Jun N-
terminal kinase-dependent or Ca2+-dependent pathways
[15]. There is crosstalk between Wnt-5a ligand expres-
sion and transforming growth factor β1 (TGF-β1) [12].
TGF-β1 is one of the major players in determining the
structural and functional abnormalities of airway smooth
muscle in asthma [9]. The interaction between TGF-β1
and Wnt-5a is associated with various pathophysio-
logical functions in asthma [12]. Expression and activa-
tion of TGF-β1 leads to airway remodeling in asthmatic
lungs [17] and may induce Wnt signaling in human
ASMC [18].
We hypothesized that eosinophils promote ASMC
proliferation through elevated ECM protein (fibronectin
and collagen) production induced by altered Wnt-5a and
TGF-β1 expression in asthma. To test this hypothesis,
we used co-cultures of peripheral blood eosinophils
isolated from asthma patients or healthy individuals and
healthy immortalized human ASMC.
Methods
Subjects
A total of 18 nonsmoking adults (men and women) were
examined: 8 patients with persistent mild to moderate
asthma defined according the GINA criteria and 10
healthy subjects who comprised the control group. The
patients were recruited from the Department of Pulmo-
nology and Immunology, Hospital of the Lithuanian
University of Health Sciences, Kaunas. The study proto-
col was approved by the Regional Biomedical Research
Ethics Committee of the Lithuanian University of Health
Sciences (BE-2-13), and each participant gave his/her in-
formed written consent.
Patients with asthma had a clinical history of the
disease for ≥1 year, current symptoms, airway hyper-
responsiveness and positive skin prick test (≥3 mm)
in response to house dust mites Dermatophagoides
pteronyssinus (D. pteronyssinus) or Dermatophagoides
farinae (D. farinae). All patients were not using inhaled,
nasal or oral steroids at least 1 month before visits,
short-acting β2 agonists at least 12 h and long-acting
β2 agonists at least 48 h prior the lung function test,
antihistamines and antileukotrienes – 7 days before
skin prick test and prior the lung function test. None
of the patients had a history of smoking. Baseline
forced expiratory volume in one second (FEV1) was
more than 70 % of the predicted value in all patients.
All healthy subjects were nonsmokers, without symptoms
of rhinitis or asthma, with normal findings of spirometry
and methacholine challenge, and all showed negative re-
sults of skin prick test (Table 1).








Age (years) 32.0 ± 3.4 26.2 ± 0.9
Gender (M/F), n 3/5 3/7
FEV1 (L) 3.92 ± 0.23 3.68 ± 0.21
FEV1 (% of predicted) 109.6 ± 3.6 100.7 ± 2.7
Wheal diameter induced by allergen (mm) 4.8 ± 0.6 0
PD20 (mg) 0.11
a –
Blood eosinophil count (x 109/L) 0.23 ± 0.05* 0.12 ± 0.01
Sputum eosinophil count (× 109/L) 0.09 ± 0.01* 0.03 ± 0.004
F female, M male
FEV1 – forced expiratory volume in one second
PD20 – the provocation dose of methacholine causing a 20 % decrease in FEV1
Data presented as Mean ± standard error of the mean
*p < 0.01 comparing with healthy subjects peripheral eosinophils count
aGeometric mean
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Study design
All subjects were informed about the requirements for
participation in the study, informed written consent was
obtained, inclusion/exclusion criteria were verified, and
physical examination, spirometry, a methacholine chal-
lenge test, and a skin prick test were performed. Peripheral
blood was taken if an individual met the criteria for the
study. After extraction of eosinophils, for each study
participant a separate co-culture with healthy ASMC
was prepared. ASMC were cultured for 3 days in medium
with serum and 1 day in serum-free medium with insulin-
transferrin-selenium reagent, as described below, before
co-culture. After 30, 45, 60, 120, and 240 min of co-
culture, eosinophil adhesion was measured. After 24 h of
co-culture, samples were collected for gene expression
analysis. ASMC proliferation was measured after 48 and
72 h. Before the collection of samples for gene expression
analysis and before ASMC proliferation measurements, all
wells were incubated for 4 min with phosphate-buffered
saline (PBS) containing 1 mM ethylenediaminetetraacetic
acid (EDTA) until eosinophils detached from ASMC. This
was done to avoid errors in gene expression and ASMC
proliferation results caused by nonhomogeneous ASMC
preparations. EDTA is a chelator of divalent ions than can
suppress eosinophil adhesion through integrins by binding
calcium ions. Because adhesion of eosinophils to ASMC is
weaker than adhesion of ASMC to culture dishes, the in-
cubation with PBS and EDTA allowed separation of these
two types of cells. To confirm complete removal of eosin-
ophils from ASMC, the cultures were observed through a
microscope after all experiments. Samples for gene ex-
pression were lysed and cell proliferation was measured
immediately after removal of EDTA from the culture to
avoid adverse effects on cell viability.
Lung function testing
Pulmonary function was tested using a pneumotacho-
metric spirometer “CustovitM” (Custo Med, Germany).
Baseline forced expiratory volume in one second (FEV1),
forced vital capacity (FVC), and FEV1/FVC ratio were
recorded as the highest of three reproducible measure-
ments. The results were compared with the predicted
values matched for age, body height, and sex according
to the standard methodology.
Measurement of airway responsiveness to methacholine
Airway responsiveness was assessed as changes in airway
function after challenge with inhaled methacholine using
a reservoir method. Methacholine was nebulized into a
10-L reservoir with a pressure nebulizer (Pari Provoca-
tion I; Pari, Stanberg, Germany). Aerolized methacholine
was inhaled through a one-way valve at 5-min intervals
starting with 15-μg methacholine dose and doubling it
until a 20 % decrease in FEV1 from the baseline or the
total cumulative dose of 3.87 mg was achieved. The
bronchoconstricting effect of each dose of methacholine
was expressed as a percentage of decrease in FEV1 from
the baseline value. The provocative dose of methacholine
causing a ≥ 20 % fall in FEV1 (PD20) was calculated from
the log dose–response curve by linear interpolation of
two adjacent data points.
Skin prick testing
All patients were screened for allergy by the skin prick
test using standardized allergen extracts (Stallergenes
S.A., France) for the following allergens: D. pteronyssi-
nus, D. farinae, cat and dog dandruff, 5 mixed grass
pollen, birch pollen, mugwort, Alternaria, Aspergillus
and Cladosporium. Temoin was used for a negative con-
trol, and histamine hydrochloride (10 mg/mL) was used
for a positive control. Skin testing was read 15 min after
application. The results of skin prick test were consid-
ered positive if the mean wheal diameter was ≥ 3 mm.
Analysis of peripheral blood cells
The analysis of peripheral blood cells was performed on
an automated hematology analyzer XE-5000™ (Sysmex,
Japan).
Sputum induction, processing and cells analysis
After baseline FEV1 and FVC measurements, subjects in-
haled 10 mL of sterile hypertonic saline solution (3 %, 4 %,
or 5 % NaCl, Ivex Pharmaceuticals, USA) at room
temperature. Nebulised solution was given for three pe-
riods of 5 min at most by an ultrasonic nebuliser ULTRA-
NEB™ (DeVilbiss, USA). The subjects were instructed to
cough sputum into containers. If any symptoms occurred,
nebulisation was discontinued. It was stopped after
expectoration of an adequate amount of sputum. In
order to detect a possible decrease in FEV1, spirom-
etry was performed after each inhalation. Sputum was
poured into a Petri dish and separated from saliva. A
4-fold volume of freshly prepared 0.1 % dithiothreitol
(DTT; Sigma-Aldrich) was added. The mixture was
vortexed and placed on ice and rocked on an orbital
shaker OS-10 (BIOSAN, Latvia) for 15 min. Next, an
equal volume of phosphate-buffered saline solution
(PBS; Sigma-Aldrich) was added to DTT. The cell pellet
was separated using a 40-μm cell stainer (Becton
Dickinson, USA). The mixture was centrifuged for 10 min
at 4 °C; the supernatant was aspirated and stored at
−70 °C for later analysis. The total cell counts, percentage
of epithelial cells, and cell viability were investigated using
a Neubauer hemocytometer (Heinz-Herenz, Germany)
under a microscope (BX43, OLYMPUS, USA) by employ-
ing the Trypan blue exclusion method. The cytospin
samples of induced sputum were prepared using a
cytofuge instrument (Shandon Southern Instruments,
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USA). Supernatant with and without DTT was stored
in 2 mL microtubes at −70 °C for further researches.
The prepared sputum cytospins were stained by the
May-Grünwald-Giemsa method for differential cell counts.
Cell differentiation was determined by counting approxi-
mately 400 cells in random fields of view under a light
microscope, excluding squamous epithelial cells. The cells
were identified by standard morphological criteria, nuclear
morphology, and cytoplasmic granulation.
Peripheral blood collection and isolation of eosinophils
Peripheral blood samples for eosinophil isolation were
collected into sterile Vacutainer tubes with EDTA. Poly-
morphonuclear leukocytes (PMN) were isolated by high-
density gradient centrifugation. The whole blood was lay-
ered on Ficoll-Paque PLUS (GE Healthcare, Finland) and
centrifuged at 1000 × g for 30 min at room temperature,
and then PMN were separated by hypotonic lysis of eryth-
rocytes. Eosinophils were separated using a magnetic eo-
sinophil isolation kit (Miltenyi Biotec, USA). MACS buffer
(containing 0.5 % bovine serum albumin (BSA) and 2 mM
EDTA in PBS, pH 7.2) was prepared by diluting MACS
BSA Stock Solution 1:20 in autoMACS Rinsing Solution.
The granulocyte pellet was resuspended in cold MACS
buffer (40 μL per 1 × 107 cells) and incubated with Biotin-
Antibody Cocktail (biotin-conjugated monoclonal anti-
bodies against CD2, CD14, CD16, CD19, CD56, CD123,
and CD235a (glycophorin A)) (10 μL per 1 × 107 cells) for
10 min. After incubation, 20 μL of Anti-Biotin MicroBeads
(microbeads conjugated to monoclonal mouse anti-biotin
IgG1) per 1 × 107 cells was added, mixed, and incubated
for an additional 15 min at 4 °C. An LS column (Miltenyi
Biotec, USA) was prepared during this time by placing the
column in the magnetic field of a MACS Separator and
washing it with 2 mL of MACS buffer. A pre-separation fil-
ter (30 μm; Miltenyi Biotec) was rinsed with MACS buffer
and placed on top of the column. The cells were then
applied to the pre-separation filter/LS column, and the
magnetically labeled non-eosinophils were retained on
the column in the magnetic field of the Separator while
the unlabeled eosinophils passed through the column.
Cells were eluted with 5 mL of MACS buffer and centri-
fuged (400 × g, 10 min, 4 °C), and the pellet was resus-
pended in 1 mL of Dulbecco’s modified Eagle’s medium
(DMEM) (Biological Industries, Israel) to a final concentra-
tion of 2 × 106 cells/mL. Eosinophils were counted using
an ADAM automatic cell counter (Witec AG, Switzerland).
Blood eosinophil viability was assessed by Trypan Blue ex-
clusion and found to be at least 98 %. To check eosinophil
purity after magnetic separation, a diluted eosinophil sus-
pension was fixed with methanol on a glass plate, stained
with May–Grunwald–Giemsa dyes, and inspected by light
microscopy to determine whether there were any neutro-
phils in the suspension.
Airway smooth muscle cell culture
Healthy human ASMC isolated from one donor and im-
mortalized by stable expression of hTERT were used for
the experiments [19]. Cells were maintained in 75 cm2
Falcon culture flasks under standard culture conditions
of 5 % CO2 in air at 37 °C with medium renewal every
2–3 days. For all experiments, passaged cells were grown
on plastic dishes in DMEM (GIBCO® by Life Technolo-
gies, Paisley, UK) supplemented with streptomycin/peni-
cillin (2 % v/v; Pen-Strep, GIBCO® by Life Technologies,
Paisley, UK), amphotericin B (1 % v/v; GIBCO® by Life
Technologies), and fetal bovine serum (10 % v/v; GIBCO®
by Life Technologies). Cells were transferred and medium
was refreshed every 48–72 h. After reaching sufficient
confluency, cells were passaged by trypsinization. Cells
were serum deprived in DMEM supplemented with anti-
biotics and insulin, transferrin, and selenium reagent
(GIBCO® by Life Technologies) before each experiment to
stop cell proliferation and avoid possible errors in prolifer-
ation and gene expression measurements due to the effect
of serum in the growth medium.
Co-culture of airway smooth muscle cells and eosinophils
For all experiments, individual co-cultures of eosinophils
and human bronchial smooth muscle cells were pre-
pared. We used 0.5 × 105 viable eosinophils and 2 × 105
ASMC for all experiments except the one shown in
Fig. 1, in which 2 × 105 viable eosinophils were used. For
cell visualization, we used an inverted microscope (CETI
Inverso TC100, Medline Scientific, UK) with a 10×/22 mm
wide-field eyepiece and PH 10×/0.25 objective and an
installed CETI Si-5C camera (Si-Cap software, Version
2.1, 2012).
Eosinophil adhesion assay
ASMC were seeded in 6-well plates (1 × 104 per well)
and grown in DMEM for 3 days in 5 % CO2 at 37 °C.
Then, the medium was removed and wells were washed
twice with PBS. DMEM without fetal bovine serum but
supplemented with 10 % insulin-transferrin-selenium re-
agent was added, and cells were incubated for 1 day. Next,
a co-culture with eosinophils was prepared. Eosinophils
were allowed to adhere to ASMC for 30, 45, 60, 120, and
240 min. After incubation, non-adhered cells were re-
moved and the remaining cells were washed twice with
PBS. Eosinophil adhesion was determined by measuring
residual eosinophil peroxidase (EPO) activity of adherent
cells as previously described [20]. Because intercellular
EPO levels are decreased in eosinophils from asthmatic
individuals owing to degranulation [21], increased EPO
activity can be determined for higher numbers of eosino-
phils stably adhering to the ASMC surface. In Fig. 2 we
provide visual confirmation of an increased number of
asthma-associated eosinophils stably adhering to ASMC.
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To assay EPO activity, 462 μL of RPMI-1640 medium
without phenol red and 462 μL of EPO substrate (1 mM
H2O2, 1 mM o-phenylenediamine, and 0.1 % Triton X-100
in Tris buffer, pH 8.0) were added to each well. After
30 min at room temperature, 231 μL of 4 M H2SO4 was
added to each well to stop the reaction and the absorb-
ance was measured at 490 nm in a microplate reader. Re-
sults are expressed relative to substrate oxidation levels in
control cells (ASMC cultured without eosinophils). The
absorbance in control cells is presented as 100 % and
eosinophil adhesion is expressed as the difference from
the control value.
Alamar blue proliferation assay
Cells were grown in 6-well cluster plates. ASMC prolif-
eration was assessed as described previously. Healthy
ASMC were co-cultured with eosinophils isolated from
asthma patients and healthy individuals for 48 and 72 h.
Thereafter, all cells were washed once with warm PBS
and incubated for 4 min with warm PBS supplemented
with 1 mM EDTA to detach eosinophils from ASMC.
Proliferation was evaluated by incubating wells with
Hank’s Balanced Salt Solution containing Alamar blue
solution (10 % v/v; Invitrogen™ by Life Technologies,
Paisley, UK). Conversion of Alamar blue to the re-
duced form was dependent on the metabolic activity
of ASMC and was assayed by dual-wavelength spec-
trophotometry at wavelengths of 570 nm and 600 nm.
As indicated by the manufacturer, the degree of Ala-
mar blue conversion is proportional to the number of
viable cells. The data are expressed as the percent in-
crease or decrease in Alamar blue conversion by ASMC
compared with control cells (ASMC cultured without
eosinophils), which did not proliferate during the co-
culturing period.
RNA isolation and real-time PCR
ASMC co-cultured with eosinophils and control ASMC
(cultured under the same conditions but without eosino-
phils) were prepared for total RNA extraction by wash-
ing the cells with warm PBS and incubating them for
4 min with warm PBS supplemented with 1 mM EDTA
to detach eosinophils. Total RNA was extracted using
the miRNeasy Mini Kit (QIAGEN, USA) according to
the manufacturer’s instructions. Then, real-time PCR
was performed using the Power SYBR® Green RNA-to-
CT™ 1-Step Kit (Applied Biosystems, USA) in a 7500 Fast
Real-Time PCR System, as follows: reverse transcription
Fig. 1 Combined culture of airway smooth muscle cells (ASMC) and eosinophils. a ASMC incubated alone on the first day of cultivation.
b Combined culture of confluent ASMC and eosinophils from asthmatic subjects after 30 min of incubation, demonstrating the interaction of ASMC
with eosinophils. c Combined culture of confluent ASMC with eosinophils from asthmatic individuals after 30 min of incubation and three washes
with warm phosphate-buffered saline (PBS), demonstrating the proportion of eosinophils stably adhering to viable ASMC. d ASMC after 4 min of
incubation with warm PBS containing 1 mM EDTA, demonstrating effective separation of combined cultures. Sufficient confluency was considered to
be 75 %, equivalent to 2 × 105 ASMC. Eosinophils from asthmatic subjects were seeded at 2 × 105 cells per well. Magnification in panels A and
D: wide-field eyepiece, ×10; objective, ×10. Magnification in panels B and C: wide-field eyepiece, ×20; objective, ×10
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at 48 °C for 30 min; activation of AmpliTaq Gold® DNA
Polymerase, UP (Ultra-Pure) at 95 °C for 10 min; and
40 cycles of denaturation at 95 °C for 15 s and annealing
and extension at 60 °C for 1 min. Real-time PCR data
were analyzed using the comparative cycle threshold
method (the amount of target gene was normalized to
the endogenous reference gene 18S ribosomal RNA). A
difference of 1 Cq (ΔCq = 1, where Cq is the amplifica-
tion cycle number) after normalization to the reference
gene indicates a twofold higher expression level of the
investigated gene. Relative differences were determined
by normalization of test sample ΔCq values to control
sample ΔCq values with the equation ΔCq(control)
−ΔCq(test). The following primers were used to analyze
gene expression: Wnt-5a, Fwd 5′-GGG TGG GAA CCA
AGA AAA AT-3′ and Rev 5′-TGG AAC CTA CCC
ATC CCA TA-3′; TGF-β1, Fwd 5′-GTA CCT GAA
CCC GTG TTG CT-3′ and Rev 5′-GAA CCC GTT
GAT GTC CAC TT-3′; 18S rRNA, Fwd 5′-CGC CGC
TAG AGG TGA AAT TC-3′ and Rev 5′-TTG GCA
AAT GCT TTC GCT C-3′; collagen type Iα1, Fwd 5′-
AGC CAG CAG ATC GAG AAC AT-3′ and Rev 5′-
TCT TGT CCT TGG GGT TCT TG-3′; and fibronec-
tin, Fwd 5′-TCG AGG AGG AAA TTC CAA TG-3′ and
Rev 5′-ACA CAC GTG CAC CTC ATC AT-3′.
Statistical analysis
Statistical analysis was performed with GraphPad Prism
6 for Windows (Version 6.05, 2014; GraphPad Software,
Inc., San Diego, CA, USA). Normally distributed data
are presented as mean and standard error of the mean
(SEM). Non-normally distributed data are expressed as
median and range and were analyzed using nonparamet-
ric tests. Significant differences between two independ-
ent groups were determined by the Mann–Whitney U
test. The Wilcoxon matched-pairs signed rank test was
used for dependent groups. Statistical significance was
assumed at a p value of <0.05.
Results
Characteristics of the studied subjects
Eighteen nonsmoking adults participated in this study:
8 steroid-free patients with intermittent or mild-to-
moderate persistent asthma, and 10 healthy subjects,
who constituted the control group. The demographic,
clinical, and laboratory data of the study subjects are
presented in Table 1. There were no significant age
or sex differences between the groups. Lung function
was similar in both groups, whereas airway hyperre-
sponsiveness and skin prick positivity were detected
only in the asthma group. The number of eosinophils
Fig. 2 Combined culture of airway smooth muscle cells (ASMC) and eosinophils from asthmatic and healthy individuals. a ASMC incubated with
eosinophils from asthmatic subjects. b Combined culture of ASMC and eosinophils from healthy subjects. c Combined culture of ASMC and
eosinophils from asthmatic subjects after 30 min of incubation and three washes with warm phosphate-buffered saline (PBS). d ASMC after
30 min of co-culture with eosinophils from healthy subjects and three washes with warm PBS. The number of eosinophils (0.5 × 105) and ASMC
(2 × 105) per well is the same in all panels. A: absorbance at 490 nm, representing eosinophil peroxidase activity in ASMC and eosinophil co-cultures.
A(control): absorbance in control ASMC cultured without eosinophils. Sufficient confluency was considered to be 75 %, equivalent to 2 × 105 cells.
Magnification: wide-field eyepiece, ×10; objective, ×10
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was significantly higher in peripheral blood and in-
duced sputum from patients with asthma compared
with healthy individuals.
Eosinophil adhesion to airway smooth muscle cells
Adhesion was expressed as EPO substrate oxidation (ab-
sorbance at 490 nm) in co-cultures of eosinophils and
ASMC relative to EPO substrate oxidation in control
ASMC (cultured without eosinophils); the control value
is set as 100 %, and eosinophil expression is the differ-
ence from the control value. Adhesion of eosinophils
from asthma patients was significantly greater than ad-
hesion of eosinophils from healthy subjects at all time
points: 30 min (97.5 ± 15.2 % vs 25.3 ± 4.1 %; p < 0.05),
45 min (78.2 ± 13.6 % vs 24.8 ± 6.9 %; p < 0.05), 60 min
(112.9 ± 19.2 % vs 41.1 ± 7.7 %; p < 0.05), 120 min
(83.4 ± 16.3 % vs 40.9 ± 7.8 %; p < 0.05), and 240 min
(78.5 ± 15.2 % vs 29.0 ± 9.0 %; p < 0.05). Moreover, the
adhesion of eosinophils to ASMC did not differ among
time points within the asthma patients group or within
the healthy subjects group (Fig. 3).
Effect of eosinophils on expression of Wnt-5a and TGF-β1
genes in airway smooth muscle cells
After 24 h of co-culture with eosinophils from asthmatic
subjects (0.5 × 105 eosinophils and 2 × 105 ASMC), Wnt-
5a gene expression in ASMC increased 4.80 ± 1.34 fold
(mean ± SEM; p < 0.05) compared with control ASMC
cultured without eosinophils (Fig. 4). No significant ef-
fect on Wnt-5a gene expression was detected after incu-
bation of ASMC with eosinophils from healthy subjects.
Furthermore, eosinophils from both asthmatic and
Fig. 4 Effect of co-culture of airway smooth muscle cells (ASMC) with eosinophils on Wnt-5a gene expression. Gene expression was measured
after 24 h of incubation. Results are presented as mean − ΔΔCt ± SEM. Asthma patients, n = 8; healthy subjects, n = 10. *p < 0.05 compared with
eosinophils from healthy subjects; #p < 0.05 compared with control ASMC cultured without eosinophils
Fig. 3 Eosinophil adhesion to airway smooth muscle cells at various time points. Results are shown as mean ± SEM. Asthma patients, n = 8;
healthy subjects, n = 10. *p < 0.05 compared with healthy individuals. Eosinophil peroxidase substrate oxidation is expressed as the percent
difference from the absorbance in control ASMC cultured without eosinophils
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healthy subjects induced overexpression of the TGF-β1
gene in ASMC, but the effect of eosinophils from asth-
matic subjects was significantly greater (4.80 ± 0.33 fold
vs 2.56 ± 0.69 fold; mean ± SEM; p < 0.05) (Fig. 5).
Effect of eosinophils on expression of collagen and
fibronectin genes in airway smooth muscle cells
After 24 h of co-culture with eosinophils from asthma
patients (0.5 × 105 eosinophils and 2 × 105 ASMC), colla-
gen gene expression in ASMC increased 2.13 ± 0.23 fold
(mean ± SEM) compared with control ASMC cultured
without eosinophils. No significant effect on collagen
gene expression was detected after incubation of ASMC
with eosinophils from healthy subjects (Fig. 6). Moreover,
eosinophils from both asthmatic and healthy subjects sig-
nificantly increased fibronectin gene expression in ASMC
compared with control ASMC cultured without eosino-
phils (1.71 ± 0.25 fold and 1.73 ± 0.20 fold, respectively;
mean ± SEM; p < 0.05) (Fig. 7).
Proliferation of airway smooth muscle cells after
co-culture with eosinophils
ASMC proliferation was measured after 48 and 72 h of
incubation with eosinophils. Proliferation results were
expressed as the percent increase in Alamar blue reagent
reduction over the control, indicating an increase in the
number of viable cells. Eosinophils from asthma patients
significantly increased ASMC proliferation after 48 h
(18.4 %, range 7.6–69.0 %, vs 5.0 %, range 3.0–11.9 %;
p < 0.05) and 72 h of co-culture (21.2 %, range 8.5–58.6 %,
vs 3.0 %, range 1.1–10.2 %; p < 0.05) (Fig. 8).
Discussion
This study showed that eosinophils from peripheral
blood of steroid-free asthma patients and healthy indi-
viduals can adhere to ASMC, enhance TGF-β1 and ECM
protein (fibronectin and collagen) gene expression in
ASMC, and increase ASMC proliferation in vitro. These
effects were significantly more pronounced after co-
culture of ASMC with eosinophils from asthmatic subjects
versus eosinophils from healthy subjects. Furthermore, eo-
sinophils from asthmatic subjects enhanced Wnt-5a gene
expression in ASMC, whereas eosinophils from healthy
subjects did not affect the expression of this gene.
Eosinophils are circulating granulocytes that are con-
sidered to be the major inflammatory cells in asthma
pathogenesis, with a major role in the development of
airway remodeling [22]. In asthma, increased airway
smooth muscle mass occurs through both cellular hyper-
trophy and hyperplasia [23]. Normally, eosinophils are not
detectable or their amount is minimal in the bronchial sub-
mucosa or bronchial secretions, whereas in asthma, eo-
sinophilic inflammation is often presented, with a strong
predominance in the submucosa close to ASMC [24].
Infiltration of eosinophils into the airway is regulated
by various chemokines and cytokines, such as eotaxin,
RANTES, IL-5, and IL-13, and involves signaling via
Rho-kinase [25, 26]. Hughes et al. demonstrated that eo-
sinophils can interact with ASMC directly through an
integrin-ligand interaction [27]. To investigate eosinophil
adhesion to ASMC, we measured eosinophil peroxidase
activity by monitoring the oxidation of o-phenylenedi-
amine in vitro. This is a reliable method for the determin-
ation of eosinophil numbers [20]. We have shown that
increased eosinophil peroxidase activity correlates with in-
creased numbers of eosinophils stably adhered to ASMC
(Fig. 2). We found that eosinophils adhere to ASMC rap-
idly and continuously during incubation periods of 30 to
240 min. These results suggest that eosinophils may ad-
here to ASMC quickly after they migrate into the airway.
Eosinophils isolated from asthma patients had significantly
increased adhesive activity compared with eosinophils iso-
lated from healthy individuals. IL-5 regulates eosinophil
functions (development, activation, migration, survival)
and, together with eotaxin, is a critical molecular switch
for the induction of blood and tissue eosinophilia [28, 29].
Fig. 5 Effect of co-culture of airway smooth muscle cells (ASMC) with eosinophils on TGF-β1 gene expression. Gene expression was measured
after 24 h of incubation. Results are presented as mean − ΔΔCt ± SEM. Asthma patients, n = 8; healthy subjects, n = 10. *p < 0.05 compared with
eosinophils from healthy subjects; #p < 0.05 compared with control ASMC cultured without eosinophils
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Eosinophils isolated from asthmatic individuals may be
more active in vivo than those isolated from non-
asthmatic individuals, leading to enhanced eosinophil ad-
hesion to ASMC because of increased levels of eotaxin
and RANTES in asthma [30, 31].
Eosinophils are the main inflammatory cells releasing
TGF-β1 in asthma [32]. A recent study revealed that
TGF-β1 may affect noncanonical Wnt signaling by indu-
cing the expression of Wnt-5a in ASMC, where it can
mediate the expression of ECM proteins [12]. To investi-
gate the effect of eosinophils from asthma patients on
Wnt-5a and TGF-β1 gene expression, we determined the
total mRNA levels of these genes in ASMC after incuba-
tion with eosinophils. Only eosinophils isolated from
asthma patients significantly increased Wnt-5a gene ex-
pression, while eosinophils from both asthmatic and
non-asthmatic individuals enhanced TGF-β1 gene ex-
pression, although the increase in TGF-β1 gene expres-
sion was significantly greater with eosinophils from
asthma patients. To our knowledge, these are the first
data describing the effect of eosinophils from asthmatic
individuals on Wnt activation in human airway smooth
muscle cells. We suggest that while eosinophils from
both asthmatic and healthy individuals increase TGF-β1
expression in ASMC, the amount of TGF-β1 in ASMC
after co-culture with eosinophils from healthy subjects is
not sufficient to activate noncanonical Wnt signaling.
Eosinophils from patients with asthma have much
greater activity and more efficaciously enhance the pro-
duction of TGF-β1 in ASMC, which in turn may affect
Wnt-5a gene expression. Moreover, the eosinophil is a
TGF-β1-producing cell, and eosinophil-derived TGF-β1
may also affect noncanonical Wnt signaling. Noncanoni-
cal Wnt signaling pathway activation is associated with
cell migration and polarity [33, 34]. To evaluate the effect
of crosstalk between TGF-β1 and noncanonical Wnt sig-
naling on ECM protein expression, we determined the ex-
pression of collagen type Iα1 and fibronectin genes in
ASMC after exposure to eosinophils. Only exposure to
peripheral blood eosinophils from asthma patients signifi-
cantly increased collagen gene expression in ASMC, while
eosinophils from both asthmatic and healthy individuals
increased fibronectin gene expression, compared with
control ASMC cultured without eosinophils. These results
Fig. 6 Effect of co-culture of airway smooth muscle cells (ASMC) with eosinophils on collagen gene expression. Gene expression was measured
after 24 h of incubation. Results are presented as mean − ΔΔCt ± SEM. Asthma patients, n = 8; healthy subjects, n = 10. *p < 0.05 compared with
eosinophils from healthy subjects; #p < 0.05 compared with control ASMC cultured without eosinophils
Fig. 7 Effect of co-culture of airway smooth muscle cells (ASMC) with eosinophils on fibronectin gene expression. Gene expression was measured
after 24 h of incubation. Results are presented as mean − ΔΔCt ± SEM. Asthma patients, n = 8; healthy subjects, n = 10. #p < 0.05 compared with
control ASMC cultured without eosinophils
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suggest that eosinophils from healthy subjects may pro-
mote expression of fibronectin, one of the main compo-
nents of ECM, by ASMC; therefore, airway remodeling in
asthma may be associated with increased expression of
another ECM protein: collagen. Moreover, our results sug-
gest that airway remodeling during asthma may be related
to increased noncanonical Wnt signaling pathway activity
due to altered eosinophil adhesion.
Direct contact of eosinophils with ASMC induces the
secretion of TGF-β1 from ASMC. Furthermore, TGF-β1
secretion is related to increased ECM protein production,
leading to enhanced proliferation in vitro [12]. In our
study, healthy human ASMC were co-cultured with eosin-
ophils from asthmatic or healthy subjects to investigate
how eosinophils promote alterations in ASMC homeosta-
sis in asthma. Noncanonical Wnt-5a signaling is activated
by and necessary for TGF-β1-induced ECM production by
ASMC [12], and ECM proteins can modulate asthmatic
ASMC proliferation via an autocrine and paracrine mech-
anism [13]. We hypothesized that greater proliferation of
these cells in asthma could be associated with a TGF-β1-
promoted disorder in noncanonical Wnt signaling as well
as increased ECM protein production. To investigate the
effect of eosinophils on ASMC proliferation, we co-
cultured ASMC with eosinophils from asthma patients
or healthy individuals and measured cell numbers after
48 and 72 h. We found that eosinophils from asthma
patients increased ASMC proliferation more signifi-
cantly than eosinophils from healthy individuals did.
We speculate that this may be because of increased
Wnt-5a gene expression after co-culture with eosino-
phils from asthmatic individuals, as discussed above.
This supposition is supported by findings that Wnt-5a
expression is increased in ASMC from asthma patients
[12] and that Wnt-5a gene expression is enriched in bi-
opsies from patients with Th2-high asthma [35].
A possible limitation of this study is that we used periph-
eral blood eosinophils instead of airway tissue eosinophils.
Normally, the eosinophils affecting ASMC have migrated
from peripheral blood into the airway [36]. Recent studies
have demonstrated that eosinophil transmigration is influ-
enced by cytokines, chemokines, and other locally pro-
duced soluble mediators that control interactions between
adhesion molecules on the surface of eosinophils and their
counter-structures on opposing cells or matrix proteins
[7]. Nevertheless, our study model is appropriate for inves-
tigations in vitro because eosinophils from asthmatic indi-
viduals are known to be primed or activated in vivo and
show enhanced responses to different stimuli in vitro [37].
Conclusions
In summary, eosinophils from patients with asthma in-
crease Wnt-5a and TGF-β1 gene expression in ASMC,
enhance the expression of collagen and fibronectin, and
promote ASMC proliferation. We propose that these ef-
fects are mechanistically linked and thus, in the presence
of eosinophilic airway inflammation, these cells can con-
tribute to airway remodeling through ASMC proliferation
by activating the noncanonical Wnt signaling pathway.
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